ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
PELTHOS THERAPEUTICS INC
23.00
-0.2400
-1.03%
成交量：
2.53万
成交额：
60.57万
市值：
7,441.75万
市盈率：
-1.21
高：
24.00
开：
23.82
低：
23.00
收：
23.24
52周最高：
54.29
52周最低：
9.00
股本：
323.55万
流通股本：
136.89万
量比：
6.39
换手率：
1.85%
股息：
- -
股息率：
- -
每股收益(TTM):
-19.0707
每股收益(LYR):
-14.2710
净资产收益率：
-83.00%
总资产收益率：
-20.64%
市净率：
1.28
市盈率(LYR):
-1.61
数据加载中...
总览
公司
新闻资讯
公告
Pelthos Therapeutics公司融资将用于支持Zelsuvmi商业化，并推动Xepi与Xeglyze上市
美股速递
·
01/13
Pelthos Therapeutics Inc.盘中异动 大幅上涨5.69%报29.00美元
市场透视
·
01/08
Pelthos Therapeutics 签署重要的药品福利管理协议 扩大患者对 Zelsuvmi™ (Berdazimer) 外用凝胶的获取
美股速递
·
2025/12/04
佩尔索斯治疗公司获得Xepi乳膏在美国的独家营销权Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream
动脉网
·
2025/11/10
Pelthos Therapeutics收购Xepi®（Ozenoxacin）乳膏1%并宣布1800万美元的私人可转换票据融资
美股速递
·
2025/11/07
Pelthos Therapeutics Inc向SEC提交申请：现有股东拟发行最多814万股普通股
美股速递
·
2025/08/29
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PTHS/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":23,"timestamp":1772053200000,"preClose":23.24,"halted":0,"volume":25281,"delay":0,"changeRate":-0.01032702237521508,"floatShares":1368899,"shares":3235543,"eps":-19.070698,"marketStatus":"盘前交易","change":-0.24,"latestTime":"02-26 04:26:01 EST","open":23.82,"high":24,"low":23,"amount":605655.5267,"amplitude":0.043029,"askPrice":36.8,"askSize":200,"bidPrice":16.64,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-19.070698,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":23,"postHourTrading":{"tag":"盘后","latestPrice":23,"preClose":23,"latestTime":"16:10 EST","volume":3,"amount":69,"timestamp":1772053804720,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":6.3875274709734216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":1368899,"roa":"-20.64%","roe":"-83.00%","lyrEps":-14.271021,"volumeRatio":6.3875274709734216,"shares":3235543,"dividePrice":0,"high":24,"amplitude":0.043029,"preClose":23.24,"low":23,"week52Low":9,"pbRate":"1.28","psRate":"10.05","week52High":54.29,"institutionHeld":0,"latestPrice":23,"committee":-0.333333,"eps":-19.070698,"divideRate":0,"volume":25281,"delay":0,"ttmEps":-19.070698,"open":23.82,"prevYearClose":31,"prevWeekClose":23.24,"prevMonthClose":24.02,"prevQuarterClose":31,"fiveDayClose":19.6,"twentyDayClose":25.885,"sixtyDayClose":28.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"盘前","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1765170000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2026-02-24","current":-1.206039,"percent":0.537037,"low":-12.702408,"twenty":-10.608864,"median":-3.395418,"eighty":-1.964072,"high":-1.189404,"avg":-5.401656,"sd":3.790385,"marketCap":78986075},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-05","current":-3.422448,"twenty":-11.024224,"median":-7.763609,"eighty":-1.805104,"marketCap":80705911},{"date":"2025-12-12","current":-3.133628,"twenty":-10.952193,"median":-4.332389,"eighty":-1.816843,"marketCap":73895143},{"date":"2025-12-19","current":-2.967391,"twenty":-10.936709,"median":-3.83078,"eighty":-1.833421,"marketCap":69975058},{"date":"2025-12-26","current":-3.468719,"twenty":-10.936036,"median":-3.687312,"eighty":-1.856092,"marketCap":81797046},{"date":"2026-01-02","current":-4.057747,"twenty":-10.93065,"median":-3.642809,"eighty":-1.874014,"marketCap":95687111},{"date":"2026-01-09","current":-3.672916,"twenty":-10.883527,"median":-3.665062,"eighty":-1.88181,"marketCap":86612268},{"date":"2026-01-16","current":-3.395418,"twenty":-10.806109,"median":-3.583058,"eighty":-1.88647,"marketCap":80068505},{"date":"2026-01-23","current":-3.187295,"twenty":-10.776489,"median":-3.555764,"eighty":-1.893817,"marketCap":75160682},{"date":"2026-01-30","current":-3.374475,"twenty":-10.771103,"median":-3.506679,"eighty":-1.898477,"marketCap":79574636},{"date":"2026-02-06","current":-3.052604,"twenty":-10.742156,"median":-3.468719,"eighty":-1.919625,"marketCap":71984487},{"date":"2026-02-13","current":-2.833747,"twenty":-10.623674,"median":-3.435432,"eighty":-1.954036,"marketCap":66823556},{"date":"2026-02-20","current":-3.036408,"twenty":-10.612903,"median":-3.401675,"eighty":-1.95977,"marketCap":71602566},{"date":"2026-02-24","current":-3.349516,"twenty":-10.608864,"median":-3.395418,"eighty":-1.964072,"marketCap":78986075}],"updateTime":1772097961715},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188848364","title":"Pelthos Therapeutics公司融资将用于支持Zelsuvmi商业化，并推动Xepi与Xeglyze上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1188848364","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188848364?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 21:34","pubTimestamp":1768311298,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc. 近期成功获得融资，其募集资金将主要用于加速其核心产品Zelsuvmi的商业化进程。与此同时，公司也计划利用这笔资金正式推出另外两款重要产品——Xepi和Xeglyze，以进一步拓展其产品管线并巩固其在治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4135","PTHS","HRZN"],"gpt_icon":0},{"id":"2601833250","title":"Pelthos Therapeutics Inc.盘中异动 大幅上涨5.69%报29.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601833250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601833250?lang=zh_cn&edition=fundamental","pubTime":"2026-01-08 03:43","pubTimestamp":1767815022,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日03时43分，Pelthos Therapeutics Inc.股票出现异动，股价快速上涨5.69%。截至发稿，该股报29.00美元/股，成交量6264股，换手率0.20%，振幅3.86%。Pelthos Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Pelthos Therapeutics Inc.公司简介：Pelthos Therapeutics Inc是一家临床阶段的生物技术公司，开发和商业化新型，非阿片类，非成瘾性治疗来减轻疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","PTHS","BK4007","BK4139"],"gpt_icon":0},{"id":"1198778700","title":"Pelthos Therapeutics 签署重要的药品福利管理协议 扩大患者对 Zelsuvmi™ (Berdazimer) 外用凝胶的获取","url":"https://stock-news.laohu8.com/highlight/detail?id=1198778700","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198778700?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 20:01","pubTimestamp":1764849670,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics 签署重要的药品福利管理协议，扩大患者对 Zelsuvmi™ (Berdazimer) 外用凝胶的获取，10.3%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"gpt_icon":0},{"id":"2582381023","title":"佩尔索斯治疗公司获得Xepi乳膏在美国的独家营销权Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2582381023","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582381023?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 18:09","pubTimestamp":1762769340,"startTime":"0","endTime":"0","summary":"此协议授予Pelthos在美国境内对Xepi的分销和商业化的控制权。Xepi Cream, which contains 1% ozenoxacin, is used as an antimicrobial treatment for skin infections. The acquisition involves transferring marketing rights from Biofrontera and Ferrer to Pelthos Therapeutics, allowing the company to oversee its availability and promotion across the country.含有1%奥泽诺沙星的Xepi乳膏被用作皮肤感染的抗菌治疗。此次收购涉及将Xepi的营销权从Biofrontera和Ferrer转移至Pelthos Therapeutics，使该公司能够在全国范围内监督其供应与推广。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTHS","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"1131527726","title":"Pelthos Therapeutics收购Xepi®（Ozenoxacin）乳膏1%并宣布1800万美元的私人可转换票据融资","url":"https://stock-news.laohu8.com/highlight/detail?id=1131527726","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131527726?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520410,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics收购Xepi®（Ozenoxacin）乳膏1%并宣布1800万美元的私人可转换票据融资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"gpt_icon":0},{"id":"1118849151","title":"Pelthos Therapeutics Inc向SEC提交申请：现有股东拟发行最多814万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1118849151","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118849151?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 04:09","pubTimestamp":1756411765,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc向美国证券交易委员会提交申报文件，申请由现有股东发行最多814万股普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}